Cancer Investigation

Cancer Invest

0735-7907

1532-4192

Therapeutic Area

Oncology

Oncologists

Cancer Investigation is a well-established, international journal publishing research on all aspects of oncology. Disseminating research for more than four decades, the journal aims to provide researchers and clinicians with a comprehensive resource on the current state of progress in the field of oncology, as well as a broad background of reliable information necessary for effective decision-making. Cancer Investigation provides a unique, nimble, cutting-edge publishing platform for a broad range of topics spanning the spectrum of oncology and the rapidly changing landscape of oncology. Edited by leading clinicians and research scientists, Cancer Investigation aims to support researchers and clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. Furthermore, the editors aim to provide a premier oncology journal platform enabling timely publication and dissemination of authoritative investigations across the spectrum of oncology. Topics covered include: Clinical studies, including early phase to phase III/IV clinical trials, high quality observational studies and systematic reviews; Novel translational laboratory and biomarker studies based on clinical samples association with clinical outcomes; Rare tumors, early precision oncology and genomic medicine; Cancer supportive care and survivorship including studies incorporating quality of life and patient reported outcomes; Health services and outcomes research including studies of cancer research methodology; Cancer economics, health equities and cancer policy; The evaluation of novel technologies and their potential on revolutionizing clinical cancer research, diagnosis, and treatment; A variety of supportive literature such as, “How I Treat” reviews, conference proceedings, “Pro and Con” discussion pieces as well as articles on the “Art of Medicine” and “Mentorship and Leadership” relevant to trainees and young investigators; In addition to original clinical/translational research, the journal will consider novel translational studies that bridge the gap between the laboratory and the clinic.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines